Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Tylosin Market: By Drug Type, By Application, By Route of Administration and Geography
Tylosin Market: By Drug Type, By Application, By Route of Administration and Geography
Tylosin Market was valued at US$ 463.2 million in 2023 and is poised to grow at a CAGR of 1.8% during 2024-2030. Tylosin is an antibiotic used primarily in veterinary medicine to treat infections in animals, especially in poultry and swine. It is effective against a range of bacterial infections, including those caused by Gram-positive bacteria. Large-scale livestock operations require antibiotics like Tylosin to prevent and treat bacterial infections, supporting market growth. Also, a strong regulatory framework maintain market stability and fosters trust in the use of Tylosin. For instance, the FDA regulates Tylosin usage in animal feed in the U.S., setting strict guidelines to ensure safety and efficacy in 2023. However, increasing regulations on antibiotic use in animal farming, such as the EU’s stringent guidelines, can limit market growth and impact Tylosin usage.
Whereas, innovations in veterinary medicine and the development of new formulations can expand Tylosin’s applications and improve its effectiveness. Additionally, growth in regions like Asia-Pacific and Latin America presents opportunities for market expansion as livestock production increases in these areas.
Study Period
2024-2030Base Year
2023CAGR
1.8%Largest Market
North-AmericaFastest Growing Market
North-America
The rising global population and increasing consumption of animal protein have driven the demand for effective veterinary antibiotics like Tylosin. As countries develop economically, dietary preferences shift toward higher consumption of meat and dairy products. For instance, as of 2023, China remains one of the largest consumers of pork, driving significant demand for antibiotics in the livestock sector. Moreover, the United States increased production of poultry and swine has maintained a strong market for Tylosin. Moreover, the rising prevalence of bacterial infections in livestock significantly impacts the demand for Tylosin, an antibiotic used to treat such infections.
According to WHO, the rise in antibiotic-resistant bacterial strains poses a significant challenge in both human and veterinary medicine. This highlights the need for effective antibiotics like Tylosin, although there is also a push for careful use to prevent resistance. For instance, in 2021, outbreaks of Swine Dysentery (caused by Brachyspira hyodysenteriae) in North America led to substantial economic losses. The use of Tylosin helped manage these outbreaks and minimize production losses.
North America dominates the market due to high levels of industrial livestock farming and advanced veterinary healthcare systems. The U.S. has significant Tylosin usage in the poultry and swine industries. For instance, according to the USDA, the U.S. poultry industry alone produces more than 9 billion broiler chickens annually. This large-scale production necessitates effective antibiotics to manage health and prevent disease outbreaks. Also, in 2023, the U.S. consumed approximately 225 pounds of meat per capita, including beef, pork, and poultry (USDA). This high consumption drives demand for Tylosin to support meat production. Such a large scale necessitates effective antibiotics to prevent and treat infections. Europe has strong market presence due to stringent regulations ensuring safe use of antibiotics in animals. Whereas Asia Pacific is rapidly growing market driven by increasing meat consumption and industrial farming.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 463.2 million |
|
Market CAGR |
1.8% |
|
By Drug Type |
|
|
By Application |
|
|
By Route of Administration |
|
Download Free Sample Report
Tylosin is used to treat bacterial infections in animals, particularly in poultry and swine.
Increasing global demand for animal protein and the need to ensure animal health drive Tylosin's market demand.
Yes, recent approvals include the 2018 FDA approval for use in poultry feed and 2020 updates from the European Medicines Agency.Yes, recent approvals include the 2018 FDA approval for use in poultry feed and 2020 updates from the European Medicines Agency.
North America leads the Tylosin market due to its large-scale industrial livestock farming and advanced veterinary healthcare systems.North America leads the Tylosin market due to its large-scale industrial livestock farming and advanced veterinary healthcare systems.
| 1.Executive Summary |
| 2.Global Tylosin Market Introduction |
| 2.1.Global Tylosin Market - Taxonomy |
| 2.2.Global Tylosin Market - Definitions |
| 2.2.1.Drug Class |
| 2.2.2.Application |
| 2.2.3.Route of Administration |
| 2.2.4.Region |
| 3.Global Tylosin Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Tylosin Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Tylosin Market By Drug Class, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Tylosin Phosphate |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Tylosin Tartrate |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Others |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Tylosin Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Felines |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Canines |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Livestock |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Tylosin Market By Route of Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Oral |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Injectable |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8.Global Tylosin Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Tylosin Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Tylosin Phosphate |
| 9.1.2.Tylosin Tartrate |
| 9.1.3.Others |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Felines |
| 9.2.2.Canines |
| 9.2.3.Livestock |
| 9.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Oral |
| 9.3.2.Injectable |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Tylosin Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Tylosin Phosphate |
| 10.1.2.Tylosin Tartrate |
| 10.1.3.Others |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Felines |
| 10.2.2.Canines |
| 10.2.3.Livestock |
| 10.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Oral |
| 10.3.2.Injectable |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Tylosin Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Tylosin Phosphate |
| 11.1.2.Tylosin Tartrate |
| 11.1.3.Others |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Felines |
| 11.2.2.Canines |
| 11.2.3.Livestock |
| 11.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Oral |
| 11.3.2.Injectable |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Tylosin Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Tylosin Phosphate |
| 12.1.2.Tylosin Tartrate |
| 12.1.3.Others |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Felines |
| 12.2.2.Canines |
| 12.2.3.Livestock |
| 12.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Oral |
| 12.3.2.Injectable |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Tylosin Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Tylosin Phosphate |
| 13.1.2.Tylosin Tartrate |
| 13.1.3.Others |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Felines |
| 13.2.2.Canines |
| 13.2.3.Livestock |
| 13.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Oral |
| 13.3.2.Injectable |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Elanco |
| 14.2.2.Huvepharma |
| 14.2.3.Tairui |
| 14.2.4.Lukang Shelile |
| 14.2.5.Qilu Pharmaceutical |
| 14.2.6.Top Pharm Chemical Group |
| 14.2.7.HISUN |
| 14.2.8.Apeloa |
| 14.2.9.Elanco |
| 14.2.10.Huvepharma |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.